Önerilen Konular
Önerilen Konular
- COVID-19 23
- Development
- SARS-CoV-2
- COVID-19 (Disease) 22
- Coronavirus infections 17
- Vaccines 17
- COVID-19 Vaccines 15
- Vaccination 14
- prevention & control 13
- Betacoronavirus 12
- Research 12
- Coronavirus Infections 11
- immunology 10
- Coronaviruses 8
- Drug Development 8
- Treatment 8
- Antiviral agents 7
- Clinical trials 7
- drug effects 7
- drug therapy 7
- virology 7
- Antiviral Agents 6
- Clinical Trials as Topic 6
- Immunological aspects 6
- COVID-19 Pandemic, 2020- 5
- Chemotherapy 5
- Communicable Diseases, Emerging 5
- Mutation 5
- administration & dosage 5
- Genetic Variation 4
-
1
-
2
The immune system response to the SARS-COV-2 virus
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
3
The paediatric response to the SARS-COV-2 virus and what we can learn from it
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
4
The current understanding of the biology of the SARS-COV-2 virus
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
5
SARS-COV-2 vaccine current biological targets and considerations /
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
6
COVID-19 epidemiology and potential treatments follow up interview /
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
7
Development of an intranasal vaccine for SARS-CoV-2
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
8
SARS-CoV-2 human monoclonal antibody therapy
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
9
INFbeta therapy for COVID-19 the new SNG001 drug /
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
10
Nanotechnologies in the fight against coronaviruses
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
11
Remdesivir COVID-19 clinical trial
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
12
The development of SARS-CoV-2 vaccines
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
13
Human challenge trials for vaccines against COVID-19
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
14
The evolutionary origin of SARS-CoV-2
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
15
Imperial College London's saRNA Vaccine - COVAC1
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
16
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
17
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Baskı/Yayın Bilgisi 2020Tam Metin Erişim
Series
Elektronik İşitsel -
18
SARS-CoV-2 mutations phenotypes and implications for vaccine development /
Baskı/Yayın Bilgisi 2021Tam Metin Erişim
Series
Elektronik İşitsel -
19
The COVID-19 outbreak April 2021 update /
Baskı/Yayın Bilgisi 2021Tam Metin Erişim
Series
Elektronik İşitsel -
20
Genetic surveillance and the emergence of SARS-CoV-2 variants
Baskı/Yayın Bilgisi 2021Tam Metin Erişim
Series
Elektronik İşitsel